| Type of Biological Sample |
Components / Analytes |
Examination Technique |
Examination Procedure |
Status |
| Hematology |
| | - Optical scatter Flowcytometry
| PL-HEM-IN-005 | Active
|
| PL-HEM-IN-005 | Active
|
| | PL-HEM-IN-005 | Active
|
| | PL-HEM-IN-005 | Active
|
| PL-HEM-IN-005 | Active
|
| PL-HEM-IN-005 | Active
|
| PL-HEM-IN-005 | Active
|
| - Optical scatter Flowcytometry
| PL-HEM-IN-005 | Active
|
| | PL-HEM-IN-005 | Active
|
| PL-HEM-IN-005 | Active
|
| - Fluorescent Flow Cytometry (Abbott Alinity HQ)
| PL-HEM-IN-005 | Active
|
- Neutrophil Absolute Count
| | PL-HEM-IN-005 | Active
|
| - Fluorescent Flow Cytometry (Abbott Alinity HQ)
| PL-HEM-IN-005 | Active
|
- Lymphocyte Absolute Count
| | PL-HEM-IN-005 | Active
|
| - Fluorescent Flow Cytometry (Abbott Alinity HQ)
| PL-HEM-IN-005 | Active
|
| | PL-HEM-IN-005 | Active
|
| - Fluorescent Flow Cytometry (Abbott Alinity HQ)
| PL-HEM-IN-005 | Active
|
- Eosinophil Absolute Count
| | PL-HEM-IN-005 | Active
|
| - Fluorescent Flow Cytometry (Abbott Alinity HQ)
| PL-HEM-IN-005 | Active
|
| | PL-HEM-IN-005 | Active
|
| - Fluorescent Flow Cytometry (Abbott Alinity HQ)
| PL-HEM-IN-005 | Active
|
| - Erythrocyte Sedimentation Rate (ESR)
| | PL-HEM-PR-002 | Active
|
| - Malaria Screening –Rapid Test
| - Flow Immunochromatographic assay
| PL-HEM-PR-003 | Active
|
| | - Clot based (Stago Sta R Max3)
| PL-HEM-PR-019 | Active
|
- Activated Partial Thromboplastin Time (APTT)
| PL-HEM-PR-008 | Active
|
| - Immuno-Turbidimetric Assay (Stago Sta R Max3)
| PL-HEM-PR-061 | Active
|
- International Normalized Ratio (INR)
| - Calculated (Stago Sta R Max3)
| PL-HEM-PR-019 | Active
|
| Immunohematology |
| - ABO/Rh Forward & Reverse Grouping
| - Column Agglutination technique (Biorad IH-500)
| PL-BB-IN-006 | Active
|
| PL-BB-IN-006 | Active
|
| PL-BB-IN-006 | Active
|
| PL-BB-IN-006 | Active
|
| Biochemistry |
| - Aspartate Aminotransferase
| - NADH (without P-5'-P) (Abbott Alinity C) Sr.No: AC04213 BackUp: AC02774
| PL-CLC-PR-232 | Active
|
| - NADH (without P-5’-P) (Abbott Alinity C) Sr.No: AC04213 BackUp: AC02774
| PL-CLC-PR-225 | Active
|
| - Colorimetric (Bromocresol Green) (Abbott Alinity C) Sr.No: AC04213 BackUp: AC02774
| PL-CLC-PR-233 | Active
|
| - Para-nitrophenyl phosphate (p-NPP) (Abbott Alinity C) Sr.No: AC04213 BackUp: AC02774
| PL-CLC-PR-253 | Active
|
| - Enzymatic/Colorimetric (Abbott Alinity C) Sr.No: AC04213 BackUp: AC02774
| PL-CLC-PR-252 | Active
|
- Enzymatic Carbonate (Bicarbonate)
| - PEP Carboxylase (Abbott Alinity C) Sr.No: AC04213 BackUp: AC02774
| PL-CLC-PR-234 | Active
|
| - Diazo Reaction (Abbott Alinity C) Sr.No: AC04213 BackUp: AC02774
| PL-CLC-PR-261 | Active
|
| - Diazonium Salt (Abbott Alinity C) Sr.No: AC04213 BackUp: AC02774
| PL-CLC-PR-260 | Active
|
| - Arsenazo III (Abbott Alinity C) Sr.No: AC04213 BackUp: AC02774
| PL-CLC-PR-262 | Active
|
| - Ion-selective electrode diluted (Indirect) (Abbott Alinity C) Sr.No: AC04213 BackUp: AC02774
| PL-CLC-PR-254 | Active
|
- Cholesterol, High Density Lipoprotein Cholesterol (HDL-C)
| - Accelerator Selective Detergent (Abbott Alinity C) Sr.No: AC04213 BackUp: AC02774
| PL-CLC-PR-255 | Active
|
- Cholesterol, Low Density Lipoprotein Cholesterol (LDL-C)
| - Measured, Liquid Selective Detergent (Abbott Alinity C) Sr.No: AC04213 BackUp: AC02774
| PL-CLC-PR-257 | Active
|
| - Enzymatic (Abbott Alinity C) Sr.No: AC04213 BackUp: AC02774
| PL-CLC-PR-263 | Active
|
| - NAC (N-acetyl-L-cysteine) (Abbott Alinity C) Sr.No: AC04213 BackUp: AC02774
| PL-CLC-PR-235 | Active
|
| - Kinetic Alkaline Picrate (Abbott Alinity C) Sr.No: AC04213 BackUp: AC02774
| PL-CLC-PR-264 | Active
|
| - Enzymatic (Hexokinase/G-6-PDH) (Abbott Alinity C) Sr.No: AC04213 BackUp: AC02774
| PL-CLC-PR-236 | Active
|
| - Ferene (Abbott Alinity C) Sr.No: AC04213 BackUp: AC02774
| PL-CLC-PR-267 | Active
|
| - Forward reaction - Lactate to Pyruvate. (IFCC) (Abbott Alinity C) Sr.No: AC04213 BackUp: AC02774
| PL-CLC-PR-256 | Active
|
| - kinetic colorimetric method (Abbott Alinity C) Sr.No: AC04213 BackUp: AC02774
| PL-CLC-PR-258 | Active
|
| - Enzymatic (Abbott Alinity C) Sr.No: AC04213 BackUp: AC02774
| PL-CLC-PR-268 | Active
|
| - Phosphomolybdate (Abbott Alinity C) Sr.No: AC04213 BackUp: AC02774
| PL-CLC-PR-269 | Active
|
| - Ion-selective electrode diluted (Indirect) (Abbott Alinity C) Sr.No: AC04213 BackUp: AC02774
| PL-CLC-PR-254 | Active
|
| - Biuret (Abbott Alinity C) Sr.No: AC04213 BackUp: AC02774
| PL-CLC-PR-270 | Active
|
| - Turbidimetric / Immunoturbidimetric (Abbott Alinity C) Sr.No: AC04213 BackUp: AC02774
| PL-CLC-PR-265 | Active
|
| - Ion-selective electrode diluted (Indirect) (Abbott Alinity C) Sr.No: AC04213 BackUp: AC02774
| PL-CLC-PR-254 | Active
|
| - Glycerol phosphate oxidase (Abbott Alinity C) Sr.No: AC04213 BackUp: AC02774
| PL-CLC-PR-271 | Active
|
- Troponin-I High Sensitive (TNIH)
| - Chemiluminescent microparticles immunoassay (CMIA) technology (Abbott Alinity I)Sr.No: AI 21834, Backup AI 21596
| PL-IMN-PR-157 | Active
|
| - Urease (Abbott Alinity C) Sr.No: AC04213 BackUp: AC02774
| PL-CLC-PR-272 | Active
|
| - Uricase (Abbott Alinity C) Sr.No: AC04213 BackUp: AC02774
| PL-CLC-PR-273 | Active
|
- Estimated glomerular filtration rate (eGFR)
| - Calculated (Abbott Alinity C) Sr.No: AC04213 BackUp: AC02774
| PL-CLC-PR-274 | Active
|
| Immunoassay |
| - Beta Human Chorionic Gonadotropin (B-hCG) Quantitative
| - Chemiluminescent microparticles immunoassay (CMIA) technology (Abbott Alinity I) Sr.No: AI 21834, Backup AI 21596
| PL-SER-PR-160 | Active
|
| - Chemiluminescent microparticles immunoassay (CMIA) technology (Abbott Alinity I)Sr.No: AI 21834, Backup AI 21596
| PL-IMN-PR-149 | Active
|
| PL-IMN-PR-150 | Active
|
| PL-IMN-PR-156 | Active
|
| Clinical Pathology |
| | - Double Indicator Principle (Clinitek Status)
| PL-POCT-PR-026 | Active
|
| - Oxidase-Peroxidase (Clinitek Status)
| PL-POCT-PR-026 | Active
|
| - Diazo reaction (Clinitek Status)
| PL-POCT-PR-026 | Active
|
| - Nitroprusside Method (Clinitek Status)
| PL-POCT-PR-026 | Active
|
| - pKa Change (Clinitek Status)
| PL-POCT-PR-026 | Active
|
| - Peroxidase activity (Clinitek Status)
| PL-POCT-PR-026 | Active
|
| - Protein-error-of-indicators (Clinitek Status)
| PL-POCT-PR-026 | Active
|
| - Esterase activity (Clinitek Status)
| PL-POCT-PR-026 | Active
|
| - Ehrlich (Clinitek Status)
| PL-POCT-PR-026 | Active
|
| - Diazonium (Clinitek Status)
| PL-POCT-PR-026 | Active
|
- Urine Microscopy (RBC, WBC, Pus cells, Crystals, Casts etc.)
| | PL-POCT-PR-026 | Active
|
| | PL-POCT-PR-026 | Active
|
| PL-POCT-PR-026 | Active
|
| - Double Indicator Principle (Manual Dipstick)
| PL-POCT-PR-026 | Active
|
| - Oxidase-Peroxidase (Manual Dipstick)
| PL-POCT-PR-026 | Active
|
| - Diazo reaction (Manual Dipstick)
| PL-POCT-PR-026 | Active
|
| - Nitroprusside Method (Manual Dipstick)
| PL-POCT-PR-026 | Active
|
| - pKa Change (Manual Dipstick)
| PL-POCT-PR-026 | Active
|
| - Peroxidase activity (Manual Dipstick)
| PL-POCT-PR-026 | Active
|
| - Protein-error-of-indicators (Manual Dipstick)
| PL-POCT-PR-026 | Active
|
| - Esterase activity (Manual Dipstick)
| PL-POCT-PR-026 | Active
|
| - Ehrlich (Manual Dipstick)
| PL-POCT-PR-026 | Active
|
